32% Rise In Breast Cancer Diagnosis In 1980s Explained By Increase In Mammography Screening
In Brief: Senate Committee Cuts House Amount For NCI; NCI Staff Faces Up to 22 Days Unpaid Leave
12 Minority CCOPs Awardees Names, San Antonio Gets 2
Miami Core Grant Not Renewed, Status Threatened
ODAC Recommends Fludarabine Approval for Refractory CLL
Advocacy Group Tells Chicago Tribune That AIDS, Not Gallo, Is Issue
Lasker Awards Resume; ASCO Fall Conference Scheduled For October
Trending Stories
- Prediction markets now allow betting on clinical trial results, FDA decisions
It’s a high-risk bet: Insider trading, equipoise, integrity of research, public trust are at stake - Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Pour a Scotch, we’re talking clinical trials and prediction markets
- Retraction is not refutation: Why chrono-immunotherapy still deserves scientific investigation
- Mount Sinai oncologist Krystal Cascetta, 40, and her infant daughter die in Somers, NY, home









